Zyla Life Sciences Operating Lease Liability
Zyla Life Sciences had Operating Lease Liability of $2.77 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2020-05-14
- 2020-03-31: Operating Lease, Liability $2.77M.
- 2019-12-31: Operating Lease, Liability $3.03M.
- 2019-09-30: Operating Lease, Liability $3.31M.
- 2019-06-30: Operating Lease, Liability $1.93M.
| Period end | Operating Lease, Liability |
|---|---|
| 2020-03-31 | $2.77M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.03M 10-K · filed 2020-03-26 |
| 2019-09-30 | $3.31M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.93M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.21M 10-Q · filed 2019-05-17 |